Browse the corpus

Doxycycline hyclate is a water-soluble, broad-spectrum tetracycline antibiotic used to treat a range of infections, including acne, sexually transmitted infections (STIs), eg, chlamydia, syphilis, and gonorrhea, Lyme disease, malaria prophylaxis, and pathogens (eg, Mycoplasma). The Centers for Disease Control now recommends doxycycline as postexposure prophylaxis (Doxy PEP) for preventing bacterial STIs in high-risk populations. In addition to its antimicrobial properties, doxycycline offers anti-inflammatory and immunomodulatory effects, making it helpful in treating conditions, eg, rosacea, rheumatoid arthritis, and periodontal disease. This course explores doxycycline's mechanism of action, bioavailability, tissue penetration, and safety profile. The adverse effects and rising concerns about resistance are also discussed. This activity reviews the intricate pharmacology of doxycycline, allowing clinicians to tailor management to individual patient needs and enabling informed decision-making when prescribing doxycycline, while minimizing adverse reactions. This activity for healthcare professionals is designed to enhance the learner's competence in administering doxycycline hyclate, applying therapeutic indications, pharmacologic mechanisms, administration protocols, and monitoring strategies, and implementing an appropriate interprofessional approach when managing cases requiring this medication. Objectives: Identify the indications for doxycycline hyclate use. Differentiate doxycycline hyclate’s mechanism of action from other antibiotic classes. Apply current guidelines for postexposure prophylaxis in appropriate patient populations. Implement interprofessional team strategies to reduce the risk of antimicrobial resistance when prescribing doxycycline. Access free multiple choice questions on this topic.

Clinical Indications of Overdose and Toxicity In rare instances, doxycycline has been associated with hepatic injury about 1 to 2 weeks after starting therapy. Hepatic injury can range from hepatocellular to cholestatic or mixed. Often, a quick onset with reported symptoms of DRESS syndrome is noted, eg, rash, fever, and eosinophilia.[54] Acute doxycycline hepatitis has been noted in patients receiving treatment for pulmonary actinomycosis after 1.5 months of 200 mg of doxycycline daily. Liver function tests revealed markedly elevated levels of alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT). Liver biopsy demonstrating centrilobular necrosis was also noted, indicative of toxic hepatitis.[55] A liver reaction with nonspecific hepatitis appeared within 24 hours of oral doxycycline therapy in a patient with a suspected pneumonia infection. The diagnosis was confirmed with a liver biopsy showing cholestasis and inflammation, as well as increased liver enzymes (ALT, AST, ALP).[56] Management of Overdose and Toxicity Management focuses on stopping doxycycline, after which liver function typically improves within weeks, although severe cholestatic injury may take up to 2 to 6 months to resolve. Supportive care includes regular monitoring of liver enzymes and the management of symptoms. Corticosteroids are not routinely recommended but may be considered in rare cases of suspected immune-mediated injury, although evidence is limited. Reexposure to doxycycline should be avoided. Caution is also advised when prescribing other tetracyclines (eg, minocycline) given the potential, though unproven, risk of cross-reactivity.[39][28]

Doxycycline hyclate is a broad-spectrum tetracycline antibiotic used to treat a wide range of bacterial infections and inflammatory conditions. Applications include acne, STIs, malaria prophylaxis, and Doxy PEP. With the expanding clinical uses and emerging concerns about resistance, proper prescribing and monitoring are crucial for ensuring safe and effective treatment. Antimicrobial stewardship stresses the importance of responsible prescribing, eg, avoiding the use of doxycycline without confirmed susceptible bacterial strains or a clear prophylactic indication, to prevent the development of drug-resistant bacteria.[57] To enhance patient-centered care, clinicians must apply evidence-based guidelines and monitor for potential adverse effects. Physicians and advanced practitioners play a key role in diagnosing, initiating treatment, and evaluating risk factors, while pharmacists ensure accurate dosing and assess for drug interactions. Nurses support patient education, monitor adverse effects, and reinforce adherence. Infectious disease specialists should be consulted if there is diagnostic ambiguity or treatment failure. Effective interprofessional communication enables the timely identification of complications, reinforces antimicrobial stewardship, and improves care transitions. Coordinated team strategies between physicians, advanced practice practitioners, nurses, and pharmacists ensure optimal patient outcomes, safety, and performance by aligning roles in prevention, monitoring, and education.